exacerb
primari
caus
morbid
mortal
children
asthma
occur
despit
current
treatment
establish
major
exacerb
provok
viral
respiratori
infect
notabl
rhinovirus
rv
howev
exacerb
also
occur
absenc
furthermor
even
children
sever
asthma
major
respiratori
infect
progress
fundament
question
cold
lead
exacerb
fulli
answer
similar
differ
mechan
virusassoci
nonvir
exacerb
unknown
identifi
molecular
pathway
underli
progress
cold
exacerb
potenti
improv
understand
mechan
event
inform
target
therapeut
strategi
precis
effect
benefici
effect
exacerb
prevent
seen
type
eosinophilmodul
monoclon
antibodi
support
import
relat
howev
therapi
reduc
rather
elimin
exacerb
correct
physiolog
abnorm
asthma
therebi
confirm
contribut
addit
factor
genesi
respiratori
epitheli
inflamm
particular
signal
demonstr
import
role
rvinduc
sever
addit
immun
pathway
link
asthma
exacerb
gener
target
current
evid
yet
fulli
establish
multipl
interact
molecular
pathway
may
lead
asthma
exacerb
systemsscal
data
collect
network
analysi
facilit
unbias
mechanist
diseas
approach
ad
novel
inform
understand
howev
previou
asthma
omic
studi
design
determin
molecular
network
specif
asthma
exacerb
therefor
perform
first
studi
asthma
use
transcriptom
network
analysi
longitudin
studi
design
studi
prospect
evalu
cohort
children
high
diseas
burden
combin
nasal
viru
pcr
nasal
peripher
blood
cell
differenti
nasal
blood
rnaseq
serial
sampl
collect
baselin
longitudin
episod
particip
report
cold
symptom
determin
key
molecular
pathway
associ
subsequ
asthma
exacerb
combin
cell
deconvolut
weight
gene
correl
network
analysi
wgcna
linear
mixedeffect
model
establish
repertoir
cellular
transcript
pathway
underpin
asthma
exacerb
includ
distinct
pathway
virusassoci
nonvir
exacerb
kinet
pathway
lead
exacerb
predictor
exacerb
risk
respons
system
corticosteroid
therapi
result
constitut
unbias
detail
sensit
systemslevel
mechanist
summari
substanti
advanc
understand
immunopathogenesi
asthma
exacerb
moreov
method
provid
framework
vivo
investig
mechan
therapeut
intervent
enrol
children
year
old
daili
inhal
corticosteroid
ic
requir
least
fluticason
equival
histori
least
two
exacerb
treat
system
corticosteroid
andor
hospit
previou
month
blood
eosinophil
concentr
collect
nasal
lavag
peripher
blood
sampl
enrol
period
without
cold
symptom
asthma
exacerb
baselin
onset
respiratori
ill
character
common
cold
symptom
term
event
includ
two
sampl
within
cold
symptom
onset
per
event
fig
particip
follow
two
event
month
primari
aim
studi
identifi
pattern
gene
express
induc
event
progress
asthma
exacerb
exacerb
ex
defin
clinic
symptom
result
system
corticosteroid
use
within
cold
symptom
onset
versu
event
resolv
without
treatment
system
corticosteroid
exacerb
total
event
captur
children
ex
event
event
ex
event
one
two
sampl
collect
prior
initi
system
corticosteroid
sampl
use
primari
analysi
compar
ex
event
differ
demograph
variabl
nasal
blood
cell
differenti
tabl
viru
pcr
partial
sequenc
use
identifi
event
associ
respiratori
viru
v
virusneg
event
event
detect
respiratori
viru
posit
rva
rvc
howev
differ
viru
frequenc
type
compar
ex
event
pulmonari
function
assess
baselin
event
ex
event
associ
signific
declin
forc
expiratori
volum
predict
forc
vital
capac
ratio
demonstr
chang
pathophysiolog
measur
lung
function
associ
standard
clinic
definit
asthma
exacerb
use
studi
fig
result
confirm
high
rate
asthma
exacerb
associ
cold
symptom
popul
correspond
pathophysiolog
chang
associ
exacerb
nasal
blood
sampl
combin
measur
cell
percentag
rnaseq
data
use
cell
deconvolut
wgcna
construct
valid
repertoir
distinct
gene
express
modul
repres
divers
array
biolog
function
supplementari
fig
supplementari
tabl
gene
express
level
measur
nasal
sampl
associ
percentag
neutrophil
lymphocyt
macrophag
eosinophil
respiratori
epitheli
cell
term
epithelium
andor
squamou
epitheli
cell
term
squamou
nasal
sampl
gene
express
level
measur
peripher
blood
associ
percentag
neutrophil
lymphocyt
monocyt
eosinophil
andor
basophil
peripher
blood
appli
modular
framework
compar
ex
event
identifi
immun
pathway
underli
asthma
exacerb
express
pattern
nasal
modul
statist
significantli
associ
exacerb
falsediscoveri
rate
fdr
increas
express
ex
event
decreas
express
tabl
modul
fdr
fig
supplementari
fig
contrast
signific
differ
express
blood
modul
comparison
adjust
cell
percentag
presenc
absenc
viru
cold
symptom
variabl
primari
sourc
variabl
modul
express
supplementari
fig
differ
ex
group
result
therefor
suggest
observ
differ
predominantli
due
chang
gene
express
specif
cell
type
oppos
chang
cell
popul
composit
differenti
express
modul
repres
signific
interact
network
enrich
p
includ
import
known
asthmaassoci
gene
also
demonstr
much
broader
function
network
fig
supplementari
fig
annot
signific
exacerbationupregul
modul
epithelialassoci
cell
differenti
modul
associ
epithelium
squamou
percentag
contain
gene
form
network
center
around
transcript
factor
includ
transcript
factor
signal
molecul
induc
transform
growth
factor
tgf
signal
includ
well
gene
involv
wound
heal
epitheli
differenti
second
signific
upregul
modul
annot
eosinophil
activationmucu
hypersecret
contain
gene
associ
eosinophil
epithelium
squamou
percentag
includ
key
epitheli
mucin
associ
hypersecret
respiratori
epitheli
prolifer
marker
eosinophil
surfac
activationsurviv
molecul
eosinophil
transcript
factor
receptor
implic
dysregul
signal
repres
centralmost
gene
within
modul
network
third
signific
upregul
modul
extracellular
matrix
ecm
productioncel
membran
contain
gene
includ
asthmaassoci
collagen
membran
molecul
cftr
induc
nitric
oxid
synthas
core
gene
network
tyrosin
kinas
link
pulmonari
modul
associ
epithelium
squamou
percentag
fourth
signific
upregul
modul
epiderm
growth
factor
receptor
egfr
adhes
contain
gene
repres
import
pathway
associ
lung
mucu
form
dens
cluster
network
center
around
egfr
homolog
receptor
includ
associ
signal
molecul
associ
epithelium
squamou
percentag
signific
modul
downregul
exacerb
lymphocyt
prolifer
associ
nasal
lymphocyt
percentag
network
cell
cycl
gene
downregul
modul
annot
b
cell
receptor
bcr
signal
form
network
bcr
signal
gene
gene
relat
mrna
translat
associ
lymphocyt
percentag
result
demonstr
upregul
multipl
respiratori
squamou
eosinophilassoci
respons
downregul
lymphocyteassoci
respons
molecular
mechan
event
lead
asthma
exacerb
compar
resolv
without
exacerb
crossvalid
find
cohort
split
prespecifi
pair
unpair
analys
pair
analysi
includ
particip
experienc
one
ex
one
event
studi
thu
sampl
could
serv
control
unpair
analysi
compar
particip
contribut
ex
event
includ
particip
collect
ex
event
definit
valid
group
mutual
exclus
pair
analysi
demonstr
signific
differ
express
pattern
seven
nasal
modul
unpair
analysi
demonstr
differ
six
nasal
modul
fdr
top
four
statist
signific
modul
increas
express
ex
event
comparison
fdr
modul
observ
fullcohort
comparison
discuss
previou
section
modul
show
statist
similar
level
differ
express
independ
comparison
similarli
top
two
modul
decreas
express
ex
event
comparison
modul
found
fullcohort
comparison
discuss
previou
section
larger
unpair
cohort
modul
met
stringent
signific
threshold
fdr
smaller
pair
cohort
borderlin
signific
fdr
valu
supplementari
fig
test
robust
find
perform
bootstrap
sensit
analysi
iter
subset
full
popul
six
modul
signific
fdr
across
iter
supplementari
fig
c
result
demonstr
consist
six
exacerbationassoci
pathway
within
across
individu
given
robust
reproduc
natur
involv
six
modul
exacerb
refer
core
exacerb
modul
presenc
absenc
respiratori
viru
primari
sourc
variabl
transcriptom
data
consequ
sought
defin
molecular
signatur
exacerb
common
specif
virusassoci
nonvir
event
event
subgroup
vex
n
n
n
n
similar
viru
type
observ
v
subgroup
vex
event
posit
either
rva
rvc
supplementari
tabl
adjust
cell
percentag
modul
significantli
differ
express
among
group
fdr
tabl
express
six
previous
defin
core
exacerb
modul
significantli
differ
vex
subgroup
comparison
respect
subgroup
express
magnitud
statist
similar
ex
subgroup
confirm
pathway
core
exacerb
regardless
appar
subgroup
incit
event
supplementari
fig
anoth
seven
nasal
modul
one
blood
modul
express
specif
elev
vex
event
compar
three
subgroup
fdr
demonstr
specif
pathway
virustrigg
exacerb
vexspecif
modul
repres
numer
inflammatori
pathway
seen
event
includ
type
interferon
ifn
respons
modul
nasal
blood
sampl
contain
numer
antivir
effector
molecul
respiratori
respons
pathway
includ
associ
gene
ciliogenesi
adhes
ecm
adhes
nasal
heat
shock
protein
hsp
stress
respons
modul
also
includ
nasal
macrophageassoci
modul
chemoattractioncytotox
antigen
process
present
app
antigenpres
cell
apc
costimul
modul
highest
express
vex
event
comparison
three
group
fdr
express
modul
modestli
elev
compar
event
supplementari
fig
find
demonstr
multifacet
immun
respons
virus
intens
viral
infect
lead
exacerb
two
nasal
modul
express
specif
decreas
vex
event
comparison
three
group
modul
annot
protein
catabol
chromatin
modificationregul
gene
express
one
modul
significantli
differ
express
vex
event
type
inflamm
includ
cytokin
receptor
transcript
factor
modul
lowest
express
event
comparison
vex
event
twogroup
fdr
subgroup
express
statist
differ
vex
group
suggest
rel
lack
type
inflamm
airway
correspond
resolut
viral
cold
without
develop
asthma
exacerb
anoth
three
nasal
modul
express
specif
elev
subgroup
comparison
three
group
fdr
demonstr
specif
pathway
nonvir
exacerb
highli
associ
squamou
percentag
modul
includ
largest
modul
repertoir
annot
keratinizationepitheli
adhesiontight
junction
compos
gene
enrich
numer
barrier
function
includ
ecadherin
flg
filaggrin
two
modul
tissu
kallikreinskeratin
includ
seven
tissu
kallikrein
sever
protein
enzym
respons
cornif
squamou
epithelium
supplementari
fig
find
point
distinct
partial
squamou
initi
asthma
exacerb
trigger
absenc
viru
result
confirm
set
core
modul
common
virusassoci
nonvir
exacerb
demonstr
distinct
set
respiratori
epithelium
inflammatori
cell
pathway
involv
virusassoci
exacerb
contrast
predominantli
squamou
cell
pathway
underli
nonvir
exacerb
next
investig
kinet
modul
express
ill
ex
group
rel
baselin
valu
use
local
regress
incorpor
time
observ
transcript
chang
rel
onset
cold
symptom
express
gene
cell
differenti
modul
significantli
increas
ex
group
within
cold
onset
sustain
sever
day
throughout
event
fdr
fig
similarli
express
lymphocyt
prolifer
bcr
signal
modul
nadir
rapidli
ex
group
within
cold
symptom
onset
fdr
earli
chang
immun
respons
follow
slower
elev
later
peak
approxim
day
express
gene
eosinophil
activationmucu
hypersecret
ecm
productioncel
membran
egfr
adhes
modul
show
steadi
increas
express
ex
group
comparison
baselin
show
decreas
express
group
fdr
fig
laterpeak
modul
appear
repres
effector
function
relat
pathophysiolog
exacerb
dynam
demonstr
sequenti
pathway
activ
underli
exacerb
event
vex
subgroup
observ
express
respons
modul
peak
rapidli
within
cold
onset
wherea
express
subgroup
modul
decreas
throughout
event
fdr
fig
express
type
inflamm
modul
stay
stabl
level
vex
subgroup
wherea
steadili
decreas
subgroup
fdr
nasal
type
ifn
respons
hspsstress
respons
modul
macrophageassoci
chemoattractioncytotox
app
pathway
show
peak
express
day
express
significantli
increas
vex
event
howev
vex
event
higher
peak
express
level
higher
area
curv
line
sustain
express
gene
inflammatori
pathway
increas
level
vex
compar
event
fdr
valu
fig
subgroup
observ
three
squamousassoci
pathway
elev
express
day
express
return
toward
baselin
level
howev
model
comparison
statist
signific
fdr
longitudin
analysi
discern
kinet
model
molecular
event
underpin
cold
event
resolv
versu
lead
exacerb
next
investig
level
modul
express
baselin
healthi
visit
influenc
subsequ
risk
asthma
exacerb
compar
modul
express
level
time
baselin
first
asthma
exacerb
four
nasal
modul
significantli
associ
time
exacerb
p
supplementari
tabl
determin
optim
model
perform
forward
stepwis
regress
signific
modul
two
modul
type
inflamm
type
ifn
respons
independ
contribut
significantli
overal
model
fit
beta
coeffici
p
model
incorpor
modul
show
significantli
better
fit
anova
p
either
univari
model
specif
higher
express
type
inflamm
modul
lower
express
type
ifn
respons
modul
associ
shorter
time
exacerb
relat
exacerb
probabl
elev
ratio
type
inflamm
type
ifn
respons
express
correspond
highli
signific
risk
exacerb
short
term
individu
highest
quartil
significantli
shorter
time
exacerb
individu
lower
three
quartil
p
risk
exacerb
first
baselin
visit
fig
express
ratio
better
predictor
shortterm
exacerb
risk
collect
clinic
variabl
baselin
predict
fig
result
show
baselin
gene
express
pattern
constitut
high
express
nasal
type
inflamm
gene
low
express
type
ifn
respons
gene
robust
predictor
shortterm
exacerb
risk
examin
effect
system
corticosteroid
administr
immun
respons
studi
sampl
collect
system
corticosteroid
intervent
ex
event
period
averag
onset
cold
symptom
comparison
sampl
collect
time
window
prior
system
corticosteroid
intervent
averag
corticosteroid
induc
broad
chang
immun
pathway
alter
express
nasal
modul
nasal
eosinophil
neutrophil
percentag
well
express
blood
modul
blood
eosinophil
neutrophil
percentag
fdr
supplementari
tabl
notabl
express
subset
core
exacerbationassoci
modul
significantli
alter
system
corticosteroid
use
express
gene
eosinophil
activationmucu
hypersecret
cell
differenti
modul
return
level
equival
baselin
initi
system
corticosteroid
fig
howev
four
core
exacerb
modul
show
signific
chang
express
system
corticosteroid
among
vexspecif
modul
system
corticosteroid
use
led
signific
reduct
express
app
type
inflamm
modul
fig
result
show
system
corticosteroid
treatment
affect
subset
pathway
involv
asthma
exacerb
also
affect
multipl
biolog
process
facilit
interpret
result
develop
platform
futur
comparison
studi
gener
bipartit
network
use
entir
dataset
supplementari
fig
network
visual
cluster
coassoci
modul
cell
type
help
identifi
cooccur
molecular
event
leverag
high
degre
cluster
among
modul
cell
differenti
supplementari
fig
use
framework
similar
differ
vex
event
evid
fig
b
upregul
core
exacerb
modul
seen
common
ex
group
cluster
close
associ
airway
epitheli
cell
eosinophil
expect
also
peripher
blood
eosinophil
specif
vex
event
upregul
respons
type
inflamm
modul
cluster
togeth
demonstr
close
coassoci
near
upregul
core
modul
furthermor
observ
distinct
block
modul
repres
type
ifn
respons
well
apcrel
respons
specif
vex
event
close
associ
nasal
macrophag
lymphocyt
well
blood
monocyt
contrast
event
observ
core
modul
upregul
cluster
associ
three
upregul
squamousassoci
modul
network
use
investig
signal
within
dataset
system
corticosteroid
treatment
led
decreas
eosinophil
downregul
eosinophilassoci
modul
two
core
exacerb
modul
without
impact
exacerbationassoci
modul
fig
also
visibl
increas
airway
neutrophil
express
neutrophilassoci
modul
conjunct
previou
result
network
analysi
facilit
develop
model
molecular
event
underpin
cold
event
resolv
versu
one
lead
exacerb
effect
therapeut
intervent
system
corticosteroid
fig
determin
pathway
asthma
exacerb
occur
relat
distinct
trigger
defin
upperrespiratori
ill
provok
exacerb
wherea
other
critic
area
interest
asthma
explor
area
longitudin
transcriptom
network
analys
nasal
blood
sampl
cohort
exacerbationpron
children
previou
asthma
transcriptom
studi
limit
defin
gene
express
level
relat
stabl
activ
diseas
result
provid
systemslevel
datadriven
determin
complex
network
molecular
respons
underpin
asthma
exacerb
comparison
cold
symptom
without
exacerb
stabl
diseas
provid
import
granular
multipl
distinct
biolog
pathway
relationship
among
pathway
rel
kinet
lead
exacerb
find
consist
sever
establish
mechan
asthma
exacerb
confirm
import
highli
relev
human
studi
add
appreci
new
inform
advanc
insight
exacerb
pathogenesi
import
result
identif
relev
epithelialassoci
signal
key
earli
event
exacerb
smad
signal
protein
surrog
known
central
role
airway
inflamm
remodel
asthma
requir
airway
remodel
observ
pathway
upregul
exacerb
regardless
appar
trigger
upregul
earli
central
event
exacerb
develop
observ
may
repres
mechan
central
link
repeat
exacerb
declin
lung
activ
induc
signal
within
unit
enhanc
airway
result
support
import
type
inflamm
asthma
alarmin
synthes
respons
epitheli
damag
includ
respiratori
amplifi
innat
immun
pathway
includ
type
although
pathogen
asthma
also
key
role
tissu
function
see
link
within
respons
modul
contain
gene
relat
ciliogenesi
adhes
ecm
adhes
network
also
contain
encod
viral
sensor
induc
key
suscept
locu
childhood
encod
protein
rvc
enter
epithelium
thu
suggest
protectionrepair
process
may
leav
epithelium
suscept
repeat
infect
upregul
modul
close
associ
express
type
inflamm
modul
recapitul
known
interplay
two
key
asthma
observ
asthma
exacerb
occur
absenc
viru
character
induct
keratin
epitheli
barrier
pathway
tissu
kallikrein
may
repres
metaplasia
epithelium
toward
keratin
squamou
cell
observ
noxiou
exposur
cigarett
kallikrein
gener
kinin
includ
bradykinin
key
mediat
multipl
acut
respons
asthma
also
impact
airway
notabl
find
directli
relat
featur
airway
epitheli
barrier
dysfunct
epitheli
kallikrein
induct
asthma
exacerb
although
could
identifi
definit
etiolog
exacerb
smoke
pollut
allergen
possibl
caus
disrupt
epitheli
integr
anim
model
lead
product
demonstr
high
type
inflamm
low
type
ifn
respons
gene
express
nasal
sampl
baselin
predict
shortterm
exacerb
risk
build
previou
result
show
nasal
express
associ
exacerb
suggest
specif
atrisk
immun
state
child
highli
suscept
exacerb
furthermor
result
provid
insight
conflict
data
regard
antivir
ifn
respons
asthma
earlier
studi
shown
rel
defici
ifn
wherea
other
shown
normal
excess
data
show
observ
may
valid
ifn
respons
may
consist
diminish
elev
rather
dysregul
low
ifn
signal
baselin
may
enabl
viral
replic
andor
epitheli
damag
earli
phase
infect
secondarili
induc
exagger
ifn
respons
promot
exacerb
show
system
corticosteroid
treatment
affect
subset
exacerbationassoci
pathway
particular
relat
eosinophil
activ
mucu
hypersecret
type
inflamm
epitheli
signal
failur
corticosteroid
moder
pathway
includ
egfr
signal
ecm
product
may
help
explain
corticosteroid
treatment
limit
efficaci
prevent
lung
function
result
also
provid
exampl
definit
vivo
molecular
effect
therapeut
critic
improv
intervent
approach
major
strength
studi
prospect
design
captur
cold
symptom
natur
viral
infect
oppos
use
viral
inocul
vitro
model
use
daili
symptom
monitor
captur
event
begin
symptom
prior
clinic
exacerb
initi
system
corticosteroid
also
captur
followup
sampl
investig
progress
immun
respons
effect
system
corticosteroid
use
transcriptom
network
analysi
abl
investig
aim
unbias
manner
lead
discoveri
new
find
also
confirm
expand
upon
anticip
result
serial
combin
two
power
network
analysi
techniqu
cell
deconvolut
wgcna
novel
algorithm
distil
massiv
dataset
coher
statist
rigor
biolog
meaning
conclus
limit
approach
use
upperairway
sampl
proxi
lowerairway
event
previou
work
demonstr
nasal
epitheli
express
profil
global
similar
lower
specif
similar
key
pathway
includ
aspect
also
evid
differ
certain
immun
pathway
includ
interferon
possibl
miss
aspect
lowerairway
inflammatori
respons
directli
sampl
lower
airway
ill
howev
clear
differ
ex
event
correspond
decreas
pulmonari
function
suggest
find
reflect
molecular
pathway
directli
relev
pathophysiolog
exacerb
pair
upper
lowerairway
sampl
collect
futur
work
build
upon
result
collect
lavag
upper
airway
obtain
sampl
mixtur
inflammatori
epitheli
cell
given
clear
import
respiratori
epithelium
viral
infect
asthma
futur
studi
could
use
epitheli
brush
mean
potenti
defin
role
epithelium
exacerb
methodolog
enabl
us
obtain
signific
data
meaning
result
sampl
readili
collect
clinic
set
minim
invas
approach
success
safe
implement
children
adolesc
highrisk
popul
lowerairway
sampl
feasibl
emerg
asthma
exacerb
furthermor
modular
repertoir
network
visual
provid
platform
test
new
comparison
analyz
new
dataset
current
studi
investig
specif
intervent
intend
definit
determin
causat
vivo
platform
use
investig
granular
specif
exacerb
subtyp
effect
therapi
anticip
block
specif
compon
exacerb
pathway
conclus
demonstr
applic
transcriptom
network
analys
robust
methodolog
defin
network
immun
respons
underpin
asthma
exacerb
children
strategi
reveal
coordin
epitheli
eosinophil
pathway
upregul
well
lymphocyt
pathway
downregul
virusassoci
nonvir
exacerb
also
found
distinct
respons
viral
nonvir
exacerb
event
identifi
baselin
characterist
associ
suscept
exacerb
final
develop
new
sampl
collect
analysi
platform
readili
integr
translat
asthma
research
collect
anticip
approach
advanc
understand
efficaci
current
novel
intervent
strategi
unrespons
strategi
treat
individu
therebi
lead
clearer
comprehens
understand
asthma
exacerb
prevent
treat
prospect
longitudin
studi
design
identifi
chang
gene
transcript
coldassoci
asthma
exacerb
children
particip
recruit
across
nine
innerc
site
boston
chicago
cincinnati
dalla
denver
detroit
new
york
st
loui
washington
dc
individu
elig
enrol
year
age
diagnos
asthma
clinician
year
prior
recruit
least
two
asthma
exacerb
prior
year
defin
requir
system
corticosteroid
andor
hospit
treat
least
fluticason
deliv
one
puff
twice
daili
equival
age
year
treat
least
advair
deliv
one
puff
twice
daili
equival
age
year
older
peripher
blood
eosinophil
concentr
nonsmok
parent
legal
guardian
sign
written
inform
consent
applic
sign
assent
form
per
central
institut
review
board
irb
guidelin
individu
elig
enrol
individu
pregnant
lactat
receiv
treatment
antiig
therapi
receiv
antiig
therapi
previou
month
receiv
immunotherapi
clinic
signific
abnorm
complet
blood
count
treat
system
corticosteroid
medic
condit
includ
asthma
exacerb
within
previou
week
cold
within
previou
particip
asthmarel
pharmaceut
studi
intervent
studi
particip
studi
within
previou
week
requir
greater
fluticason
plu
longact
betaagonist
deliv
one
puff
twice
daili
equival
andor
use
oral
corticosteroid
daili
everi
day
medic
ill
opinion
investig
would
increas
risk
incur
particip
studi
interfer
measur
outcom
interfer
perform
studi
procedur
concurr
medic
problem
requir
system
corticosteroid
immunomodul
diagnos
cancer
histori
cancer
plan
move
area
primari
caretak
spoke
english
spanish
foster
child
would
allow
manag
asthma
durat
studi
abl
perform
pulmonari
function
test
known
hypersensit
medic
use
asthma
treatment
lifethreaten
asthma
exacerb
previou
year
studi
compli
relev
ethic
regul
studi
approv
central
irb
western
irb
parent
legal
guardian
child
sign
written
inform
consent
studi
procedur
complet
studi
regist
clinicaltrialsgov
particip
meet
elig
criteria
attend
screen
enrol
visit
visit
particip
follow
prospect
two
cold
event
approxim
month
visit
whichev
occur
first
particip
report
cold
symptom
return
clinic
follow
visit
visit
occur
within
onset
cold
symptom
visit
occur
onset
cold
symptom
particip
report
second
set
cold
symptom
occur
least
week
onset
first
cold
symptom
least
week
final
dose
system
corticosteroid
administ
asthma
exacerb
addit
visit
visit
visit
ident
natur
visit
visit
visit
defin
exacerb
event
ex
particip
treat
physician
system
corticosteroid
follow
onset
cold
symptom
otherwis
defin
cold
without
exacerb
criteria
initi
system
corticosteroid
previous
specifi
innerc
asthma
consortium
particip
treat
system
corticosteroid
albuterol
need
inhal
nebul
six
individu
treatment
h
moderatetosever
wheez
cough
short
breath
andor
chest
tight
pain
occur
least
preced
symptom
wheez
cough
short
breath
andor
chest
tight
pain
sever
enough
place
particip
red
zone
asthma
action
significantli
improv
three
dose
albuterol
unschedul
visit
acut
asthma
care
requir
repeat
dose
albuterol
clinician
offic
urgent
care
emerg
depart
hospit
need
asthma
addit
visit
includ
visit
month
visit
medic
manag
final
studi
visit
visit
occur
approxim
week
second
set
cold
visit
week
visit
month
visit
particip
two
set
cold
visit
throughout
studi
internetbas
asthma
cold
symptom
diari
access
particip
use
handheld
devic
provid
enrol
diari
ask
particip
assess
cold
asthma
symptom
fourpoint
visual
scale
particip
ask
complet
diari
daili
basi
symptom
cold
asthma
exacerb
report
particip
contact
day
next
weekday
studi
coordin
schedul
followup
visit
visit
diari
complianc
monitor
throughout
studi
weekli
remind
provid
studi
coordin
contact
particip
directli
assess
symptom
complianc
low
visit
particip
receiv
asthma
step
care
accord
guidelin
diagnosi
manag
asthma
expert
panel
report
treatment
supervis
studi
clinician
studi
clinician
prescrib
initi
appropri
concomit
asthma
therapi
provid
written
asthma
action
plan
particip
visit
regimen
adjust
necessari
throughout
durat
studi
basi
principl
guidelin
clinic
evalu
conduct
visit
includ
assess
follow
vital
sign
growth
paramet
height
weight
puls
rate
temperatur
blood
pressur
medic
histori
physic
examin
exhal
nitric
oxid
accord
american
thorac
societi
guidelin
pulmonari
function
accord
american
thorac
societi
european
respiratori
societi
guidelin
questionnair
includ
inform
demograph
asthma
allergi
histori
medic
use
asthma
exacerb
histori
asthma
symptom
healthcar
util
cold
symptom
concomit
medic
advers
event
allergen
skin
test
perform
visit
use
prick
techniqu
greerpick
system
allergen
assess
includ
mous
dog
cat
rat
dust
mite
cockroach
american
german
alternaria
aspergillu
ragwe
mix
eastern
tree
mix
kot
grass
mix
bermuda
grass
andor
junip
site
skin
test
perform
particip
least
use
antihistamin
blood
sampl
collect
via
peripher
venipunctur
visit
collect
rna
tempu
blood
rna
tube
thermo
fisher
scientif
assess
complet
blood
count
autom
differenti
rna
sampl
vortex
frozen
shipment
central
process
facil
blood
differenti
process
site
cliaapprov
lab
facil
standard
method
nasal
mucu
sampl
obtain
visit
respiratori
viru
assess
previous
briefli
particip
instruct
exhal
forc
nose
tissu
clear
excess
mucu
hold
one
nostril
shut
salin
spray
nostril
particip
blew
nostril
collect
baggi
procedur
repeat
opposit
nostril
use
baggi
medium
thermo
fisher
scientif
ad
collect
baggi
content
mix
store
shipment
nasal
lavag
sampl
collect
visit
nasal
lavag
collect
immedi
nasal
blow
procedur
follow
hold
head
level
particip
squeez
steril
sodium
normal
salin
sinu
rins
bottl
neilm
sinu
rins
right
nostril
falcon
collect
tube
tube
held
left
nostril
ml
fluid
collect
left
nostril
occlud
right
nostril
particip
gentli
blew
left
nostril
sever
time
separ
collect
tube
tube
next
particip
held
head
backward
approxim
angl
ml
salin
sinu
rins
bottl
squeez
right
nostril
held
nose
particip
tilt
head
forward
allow
salin
drip
collect
tube
procedur
repeat
left
nostril
use
third
collect
tube
tube
tube
entir
procedur
repeat
nostril
sampl
kept
ice
collect
collect
tube
vortex
consolid
sampl
centrifug
min
ml
supernat
remov
discard
cell
pellet
resuspend
remain
supernat
resuspend
pellet
pass
strainer
mac
smartstrain
strain
fluid
gentli
mix
pipett
homogen
sampl
ml
remov
set
asid
slide
gener
remaind
centrifug
min
supernat
remov
ml
rnaprotect
saliva
reagent
qiagen
ad
pellet
resuspend
sampl
kept
ice
andor
process
urin
collect
visit
urin
pregnanc
test
femal
reach
menarch
urin
cotinin
test
measur
exposur
environment
tobacco
smoke
nasal
blow
sampl
use
assess
respiratori
virus
multiplex
pcr
partial
sequenc
identifi
rv
speci
type
previous
reserv
ml
nasal
materi
use
gener
six
slide
cytospin
cytocentrifug
thermo
fisher
scientif
two
slide
gener
two
slide
two
slide
follow
manufactur
protocol
slide
air
dri
min
fix
stain
stain
set
thermo
fisher
scientif
accord
manufactur
protocol
nasal
cell
differenti
perform
manual
review
six
cytospin
slide
per
sampl
follow
manual
read
slide
optim
cell
densiti
distinguish
among
neutrophil
lymphocyt
macrophag
eosinophil
respiratori
epithelium
cell
squamou
cell
follow
previous
morpholog
criteria
use
identifi
six
cell
type
differenti
cell
analysi
neutrophil
segment
bi
tri
multilob
nucleu
pale
cytoplasm
stain
indistinct
cytoplasm
border
ii
lymphocyt
high
nucleartocytoplasm
ratio
small
size
relat
macrophag
iii
macrophag
vacuol
cytoplasm
round
shape
variabl
cell
size
often
eccentr
nuclei
iv
eosinophil
cytoplasm
fill
intens
pinkstain
granul
bi
tri
multilob
nucleu
v
respiratori
epithelium
cell
columnar
variabl
shape
rel
darker
cytoplasm
stain
compar
squamou
cell
andor
presenc
cilia
andor
termin
nucleu
vi
squamou
cell
larg
size
high
cytoplasmictonuclear
ratio
bland
cytoplasm
stain
two
sequenti
count
perform
sampl
slide
read
singl
experienc
individu
blind
clinic
outcom
variabl
total
rna
isol
nasal
cell
pellet
rnaprotect
saliva
reagent
qiagen
sampl
centrifug
min
supernat
remov
cell
pellet
resuspend
rlt
buffer
sampl
vortex
sonic
spun
qiashredd
column
qiagen
extract
rneasi
minelut
spin
column
qiagen
follow
manufactur
protocol
total
rna
isol
wholeblood
lysat
use
magmax
stabil
blood
tube
rna
isol
kit
tempu
blood
rna
tube
thermo
fisher
scientif
follow
manufactur
protocol
globin
mrna
deplet
use
globinclear
thermo
fisher
scientif
rna
qualiti
assess
rna
electrophoresi
agil
nanodrop
nanodrop
product
thermo
fisher
scientif
sequenc
librari
construct
total
rna
truseq
rna
sampl
prepar
kit
illumina
cluster
onto
flow
cell
use
cbot
amplif
system
hiseq
sr
cluster
kit
illumina
singleread
sequenc
carri
hiseq
sequenc
illumina
use
hiseq
sb
kit
gener
read
target
approxim
million
read
per
sampl
sampl
sequenc
four
batch
repeat
sampl
use
across
batch
allow
assess
batch
effect
result
bcl
file
deconvolut
convert
fastq
format
use
casava
illumina
fastq
file
align
ensembl
version
human
genom
genbank
assembl
tophat
version
singlepair
flag
set
singl
tophat
paramet
set
default
use
gener
gene
count
mode
set
intersect
nonempti
minimum
align
qualiti
set
paramet
otherwis
set
default
qualitycontrol
analysi
sampl
kept
million
count
percent
align
median
cv
coverag
gene
filter
includ
trim
mean
valu
tmm
normal
count
least
least
librari
classifi
protein
code
four
sampl
batch
independ
normal
within
batch
via
tmm
normal
valu
transform
count
per
million
along
observ
level
weight
use
voomwithqualityweight
limma
r
batch
process
contribut
variabl
gene
express
due
batch
effect
replic
highest
percentag
align
includ
analysi
replic
remov
final
dataset
includ
nasal
sampl
compos
gene
blood
sampl
compos
gene
celltypeassoci
gene
coexpress
modul
gener
use
sampl
collect
first
fall
enrol
season
first
two
batch
process
sampl
includ
particip
captur
cold
event
nasal
lavag
peripher
blood
sampl
cell
type
deconvolut
perform
assign
gene
cell
type
basi
statist
signific
posit
pearson
correl
gene
express
cell
differenti
accord
gene
without
cell
type
assign
consid
cell
type
specif
nasal
sampl
uniqu
proteincod
gene
cell
type
deconvolut
associ
gene
neutrophil
gene
lymphocyt
gene
macrophag
gene
eosinophil
gene
epithelium
cell
gene
squamou
cell
gene
associ
two
cell
type
gene
associ
specif
cell
type
blood
sampl
gene
cell
type
deconvolut
associ
gene
neutrophil
gene
lymphocyt
gene
monocyt
gene
eosinophil
gene
basophil
gene
associ
two
cell
type
gene
associ
specif
cell
type
gene
either
assign
cell
type
left
unassign
run
separ
cell
type
unassign
gene
within
sampl
type
give
total
nasal
modul
blood
modul
paramet
use
mincorkm
minkmetostay
indic
modul
must
block
gene
pearson
correl
least
consid
modul
gene
modul
must
pearson
correl
least
modul
eigengen
modulelevel
express
valu
calcul
use
geometr
mean
gene
assign
modul
coher
modul
assess
complet
studi
across
entir
sampl
set
span
year
studi
nasal
sampl
blood
sampl
calcul
type
assign
type
pearson
correl
intramodular
pearson
correl
compar
valu
valu
modul
gener
valu
consist
level
seen
defin
modul
highli
signific
supplementari
fig
demonstr
stabil
reproduc
modular
repertoir
popul
sever
asthmat
variabl
baselin
upperrespiratori
ill
exacerb
interest
final
cell
assign
modul
base
signific
pearson
correl
modul
cell
differenti
full
dataset
seven
nasal
modul
associ
neutrophil
five
associ
lymphocyt
five
associ
macrophag
five
associ
eosinophil
eight
associ
epithelium
cell
eight
associ
squamou
cell
five
blood
modul
associ
neutrophil
seven
associ
lymphocyt
two
associ
monocyt
two
associ
eosinophil
analys
run
r
biolog
function
modul
investig
use
databas
annot
visual
integr
discoveri
david
version
databas
use
modifi
fisher
exact
test
identifi
specif
biolog
function
categori
overrepres
gene
set
comparison
refer
set
default
human
genom
use
refer
set
modul
submit
avail
enrich
categori
download
rank
accord
fdr
modul
consid
signific
enrich
one
david
default
categori
show
enrich
fdr
modul
show
enrich
one
david
categori
term
function
annot
cluster
also
gener
use
default
categori
david
string
version
databas
known
predict
interact
use
determin
interact
network
modul
string
interact
sourc
use
minimum
interact
score
requir
gene
includ
within
network
interact
network
signific
interact
enrich
p
valu
mean
interact
expect
set
protein
size
drawn
randomli
human
genom
cytoscap
version
use
draw
interact
network
accord
prefus
forcedirect
layout
use
combin
interact
score
export
string
size
gene
made
proport
number
interact
network
percentag
maximum
number
interact
node
network
unconnect
node
exclud
summari
annot
modul
deriv
manual
inspect
modul
cell
type
assign
function
enrich
interact
network
determin
primari
sourc
variabl
modul
express
principalcompon
analysi
run
first
five
princip
compon
correl
pearson
clinic
demograph
variabl
determin
import
sourc
variabl
data
supplementari
fig
demonstr
cell
percentag
presenc
absenc
viru
visit
associ
much
variabl
nasal
blood
sampl
differ
ex
event
test
use
weight
linear
model
limma
r
empir
bay
primari
model
includ
term
exacerb
statu
cell
percentag
presenc
absenc
viru
visit
number
well
librari
sequenc
depth
multipl
sampl
came
particip
random
effect
includ
particip
model
nasal
sampl
repres
modul
express
wasdocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
begin
array
l
hfill
hfill
beta
beta
exacerb
posneg
beta
lymphocyt
beta
eosinophil
hfill
hfill
hfill
space
beta
macrophag
beta
epithelium
beta
squamou
hfill
hfill
hfill
space
beta
viral
posneg
beta
visit
ab
beta
libcount
mu
mathrm
individu
varepsilon
hfill
end
array
end
document
model
blood
wasdocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
begin
array
l
hfill
hfill
beta
beta
exacerb
posneg
beta
lymphocyt
beta
eosinophil
hfill
hfill
hfill
space
monocyt
basophil
beta
viral
posneg
hfill
hfill
hfill
space
beta
visit
ab
beta
libcount
mu
mathrm
individu
varepsilon
hfill
end
array
end
document
multipletest
correct
perform
use
method
modul
fdr
consid
signific
comparison
fdr
valu
close
signific
also
report
text
model
use
pair
unpair
subgroup
analys
sensit
analysi
perform
bootstrap
random
subset
particip
iter
subgroup
comparison
vex
presenc
absenc
viru
remov
model
ran
anova
determin
overal
signific
valu
pairwis
comparison
determin
signific
differ
across
group
corticosteroid
analysi
model
includ
variabl
cell
percentag
presenc
absenc
viru
visit
librari
sequenc
depth
test
contrast
differ
statu
ex
prec
ex
postc
within
visit
across
visit
term
presenc
absenc
viru
remov
analysi
restrict
v
event
longitudin
analysi
use
local
polynomi
regress
fit
loess
r
degre
smooth
polynomi
degre
assess
signific
linear
model
fit
bspline
basi
polynomi
spline
degre
day
cold
onset
anova
run
determin
whether
exacerb
statu
signific
studi
predict
capabl
gene
express
visit
baselin
healthi
visit
univari
linear
model
built
compar
time
exacerb
modul
express
time
exacerb
defin
time
day
visit
first
report
exacerb
individu
whether
particip
return
part
andor
b
associ
particular
ill
particip
experi
exacerb
studi
time
exacerb
censor
length
enrol
studi
two
individu
report
exacerb
later
time
day
visit
exclud
analysi
forward
stepwis
regress
perform
signific
modul
univari
analysi
comparison
time
exacerb
select
model
provid
lowest
akaik
inform
criterion
signific
p
valu
beta
coeffici
linear
combin
two
modul
sampl
divid
quartil
accord
scale
combin
express
valu
two
modul
curv
show
exacerb
probabl
time
fit
data
split
individu
accord
quartil
lower
three
quartil
overlap
significantli
differ
top
quartil
therefor
combin
comparison
curv
gener
basi
predict
split
split
quartil
curv
time
censor
display
purpos
result
similar
use
entir
length
followup
analys
run
r
present
data
methodolog
studi
resourc
research
commun
made
studi
data
r
code
publicli
avail
see
data
avail
code
avail
open
sourc
code
also
annot
demonstr
addit
secondari
analys
interest
beyond
scope
manuscript
perform
furthermor
includ
r
code
necessari
gener
modul
express
valu
modular
repertoir
defin
manuscript
novel
gene
express
dataset
run
analog
comparison
describ
studi
collect
resourc
allow
research
readili
reproduc
find
studi
perform
secondari
analys
within
dataset
use
clinic
variabl
interest
appli
modular
repertoir
defin
within
studi
new
dataset
relev
asthma
diseas
state
interest
modul
gene
express
level
cell
differenti
nasal
blood
sampl
combin
pairwis
pearson
correl
determin
respiratori
epithelium
squamou
cell
highli
correl
data
sum
analysi
hierarch
cluster
perform
creat
correl
heat
map
bipartit
network
drawn
use
cytoscap
version
accord
prefus
forcedirect
layout
signific
pairwis
correl
valu
fdr
comparison
overlaid
onto
network
color
signific
modul
accord
foldchang
valu
shrink
nonsignific
modul
categor
variabl
compar
ex
use
gener
linear
mix
model
assum
multinomi
distribut
random
effect
particip
account
correl
valu
particip
case
nonconverg
model
fisher
exact
test
use
withinparticip
correl
account
summari
display
percentag
count
continu
variabl
compar
ex
event
use
gener
linear
mix
model
assum
normal
lognorm
poisson
distribut
appropri
random
effect
particip
account
correl
valu
particip
comparison
made
assum
lognorm
distribut
valu
set
prior
model
fit
summari
display
median
first
quartil
third
quartil
p
valu
report
consid
descript
adjust
multipl
comparison
made
sa
version
softwar
sa
institut
use
analys
inform
research
design
avail
natur
research
report
summari
link
articl
method
addit
refer
natur
research
report
summari
sourc
data
statement
data
avail
associ
access
code
avail
